National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Drug Information
    Posted: 10/05/2006    Updated: 12/13/2006
Related pages
Drug Information Summaries 1

Approval Process for New Cancer Treatments 2

Access to Investigational Drugs: Q & A 3
Temozolomide

This page contains brief information about temozolomide and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):Methazolastone
Temodar
FDA Approved:Yes

Temozolomide is approved by the Food and Drug Administration (FDA) to treat two different types of brain tumor in adults: anaplastic astrocytoma and glioblastoma multiforme (GBM).

Temozolomide is also being studied in the treatment of other types of cancer.

Information from the FDA

Patient Information Sheet on Temozolomide 4 - A lay language summary of important information about this drug that may include the following:

  • FDA warnings or alerts about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This FDA patient information sheet applies only to approved uses of the medicine. However, much of the information may also apply to unapproved uses that are being studied.

FDA Approval for Temozolomide 5 - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Information from the NCI

Definition from the NCI Drug Dictionary 6 - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Temozolomide Plus Radiation Helps Brain Cancer (06/07/2004) 7 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Silenced Gene May Make Temozolomide More Effective (03/28/2005) 8 - Important clinical trial results for this drug, background information, and how the trial was done.

Information from the NLM

MedlinePlus Information on Temozolomide 9 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials

Clinical Trials for Temozolomide 10 - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.




Glossary Terms

anaplastic (an-ah-PLAS-tik)
A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.
astrocytoma (AS-troh-sy-TOH-muh)
A tumor that begins in the brain or spinal cord in small, star-shaped cells called astrocytes.
brain tumor
The growth of abnormal cells in the tissues of the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous).
cancer (KAN-ser)
A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord.
Food and Drug Administration
FDA. An agency in the U.S. federal government whose mission is to protect public health by making sure that food, cosmetics, and nutritional supplements are safe to use and truthfully labeled. The Food and Drug Administration also makes sure that drugs, medical devices, and equipment are safe and effective, and that blood for transfusions and transplant tissue are safe. Also called FDA.
glioblastoma multiforme (GLEE-oh-blas-TOH-muh MUL-tih-form)
GBM. A fast-growing type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord and has cells that look very different from normal cells. Glioblastoma multiforme usually occurs in adults and affects the brain more often than the spinal cord. Also called grade IV astrocytoma, glioblastoma, and GBM.


Table of Links

1http://cancer.gov/cancertopics/druginfo/alphalist
2http://cancer.gov/clinicaltrials/learning/approval-process-for-cancer-drugs
3http://cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access
4http://www.fda.gov/cder/consumerinfo/druginfo/temodar.HTM
5http://www.cancer.gov/cancertopics/druginfo/fda-temozolomide
6http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=41671
7http://www.cancer.gov/clinicaltrials/results/glioblastoma0604
8http://www.cancer.gov/clinicaltrials/results/glioblastoma0305
9http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601250.html
10http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41671&idtype=1